Recorded Presentations from the NCCN 2022 Nursing Program: Advancing Oncology Nursing

This program provides oncology nurses with comprehensive and clinically relevant information to optimize clinical care and patient education. The diverse program content addresses the complexities of care for patients with cancer and the dynamic role of the oncology nurse across the continuum of care. This is an exciting opportunity for oncology nurses to gain practical knowledge from leading clinical nursing experts and network with their peers in an engaging and interactive environment.

Target Audience

This program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

The goal of this activity is to ensure that oncology nurses, as members of the interprofessional oncology care team, have the knowledge and skills necessary to apply the standards of care to their practice and health care setting for patients with cancer.

Following this program, participants should be able to:

  • Evaluate advances in the management of patients with cancer and key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and apply appropriate treatment and supportive care strategies to optimize patient education and care.
  • Review issues related to Emerging Treatment Landscape of Targeted Therapies in Hematologic Malignancies; Desensitization Protocols in the Outpatient Setting; Updates in the Treatment of Lymphoma; Toxicities of CAR T-cell Therapy: Beyond CRS and Neurotoxicity; Updates in the Treatment of CNS Cancers; Communicating an Adult Diagnosis of Cancer to Children; and, Developing an Oncofertility Program to Pre-Pubertal, Adolescent and Young Adult Patients.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • AstraZeneca
  • Epizyme Inc.
  • Genentech, a member of the Roche Group
  • Novartis
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Pfizer Inc.
Course summary
Course opens: 
05/15/2022
Course expires: 
03/01/2023
Cost:
$0.00

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions 

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

Presenting Faculty
The faculty listed below have no relevant financial relationship(s) with ineligible companies to disclose.

Emely Alfaro, RN, MSN, CNS, OCN
Lynne Brophy, MSN, PMGT-BC, APRN-CNS, AOCN
Katherine L. Byar, MSN, APRN-BC, BMTCN
Claire Carlson, RN, BSN
Linda McKenna, AGACNP-BC, ANP-BC, CNS, CCRN-CMC
Jessica Shelly, CRNP, APRN
Tia Wheatley, DNP, RN, AOCNS, BMTCN, EBP-C

Moderators

The faculty listed below have no relevant financial relationship(s) with ineligible companies to disclose.

Colleen Erb, MSN, RN, AOCNP
Kristina M. Gregory, RN, MSN, OCN
Amanda E. Visnick, RN, BSN, OCN

The faculty listed below have the following relevant financial relationship(s) with ineligible companies to disclose.  All of the relevant financial relationships listed for these individuals have been mitigated.

Samantha L. Tamburro, RN, BSN, CPON
Flatiron Health, Inc.: Salary

NCCN Staff Disclosures 

The planners listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.

Crystal Denlinger, MD, FACP
Agios, Inc.: Grant/Research Support
Amgen Inc.: Grant/Research Support
Astellas Pharma US, Inc.: Scientific Advisor
AstraZeneca Pharmaceuticals LP: Grant/Research Support
BeiGene: Scientific Advisor; Grant/Research Support
Bristol-Myers Squibb Company: Scientific Advisor; Grant/Research Support
Eli Lilly and Company: Grant/Research Support
Exelixis Inc.: Scientific Advisor; Grant/Research Support
Genmab: Grant/Research Support
MacroGenics: Grant/Research Support
MedImmune Inc: Grant/Research Support
Merck & Co., Inc.: Scientific Advisor
sanofi-aventis U.S.: Grant/Research Support
Taiho Pharmaceutials Co., Ltd.: Scientific Advisor
Zymeworks: Scientific Advisor; Grant/Research Support

Samantha L. Tamburro, RN, BSN, CPON
Flatiron Health, Inc.: Salary

None of the other planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

These activities are approved for nursing contact hours. Complete accreditation information is provided before each individual educational activity.

 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing